Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Dana-Farber Registered Nurse Residency Program

  • nurse residents

    2021-2022 Residents


  • The Dana-Farber Cancer Institute Registered Nurse Residency Program is a 12-month program that builds on the education and skills of newly licensed nurses (NLNs) and prepares them to practice nursing in ambulatory oncology settings.

    Throughout this year-long position, nurse residents are immersed in all aspects of oncology nursing care in an environment that supports learning and growth. The curriculum is centered around Oncology Nursing Scope and Standards Practice (2019) and Nurse of the Future Competencies (2016).

    Residents are provided with mentorship and guidance throughout the program as they focus on developing critical reasoning in oncology, advancing their nursing skills, and increasing their comfort in providing nursing care for complex, diverse patient populations. Skill development areas include assessment, planning, implementation, and evaluation of nursing care for oncology patients.

    The Residency program works toward increasing diversity in the oncology nursing workforce at Dana-Farber by identifying nurses with experience in and commitment to working with diverse populations. The curriculum has a focus on social determinants of health and health equity.

    Successful transition into clinical nursing practice is a primary goal of this program. Upon completion of this program, residents may apply for a permanent nursing position at Dana-Farber.


  • Hope Spence, BSN, RN, and Alberto Ortega, BSN, RN
    Hope Spence, BSN, RN, and Alberto Ortega, BSN, RN, participated in the Residency Program, Infusion Track.

    "A residency gives you the time to transition into the nursing profession, and provides support and mentorship throughout the year-long program. I felt prepared when I graduated the program and confident in my practice."

    — Alberto Ortega, BSN, RN, (Graduate, Infusion Residency, 2021), currently an infusion nurse at Dana-Farber

  • Nurse Residency Specialties

    The Dana-Farber Nurse Residency Program supports two oncology specialties: Infusion and Clinical Research. Newly licensed nurses are encouraged to apply for the specialty that meets their professional goals. Annually, applications open in May and the Residency program starts in September.

    Infusion Specialty

    The Infusion Residency curriculum is structured to provide residents with rich learning experiences in both inpatient and ambulatory settings. Residents will become proficient in a variety of nursing skills, such as IV placements, central venous access devices, and infusion therapy, while practicing in an interdisciplinary team environment promoting relationship-based care. Shadowing experiences are offered with interdisciplinary team members.

    Clinical Research Specialty

    The Research Residency curriculum is structured to expose residents to fundamental clinical nursing skills, oncology-based care, and clinical research nursing competencies. The residents complete clinical rotations in inpatient oncology, ambulatory oncology, and clinical research. To supplement their clinical rotations, residents are provided a wide variety of interdisciplinary shadowing experiences and professional development opportunities.

    Eligibility

    • Baccalaureate degree in nursing from accredited nursing program
    • Licensed as a Registered Nurse in the Commonwealth of Massachusetts

    Contact Us

    Please contact us if you have questions or would like more information about the Nurse Residency Program.

    Infusion Specialty email: DFCI_ONRP@dfci.harvard.edu
    Clinical Research Specialty email: DFCI_RNRP@dfci.harvard.edu